Valuation : Grand Pharmaceutical Group Limited

Market Cap 17.6B 2.24B 1.94B 1.82B 1.66B 3.12B 213B 3.14B 21.53B 8.38B 108B 8.43B 8.24B 359B P/E 2026 *
9.1x
P/E 2027 * 8.31x
Enterprise Value 17.6B 2.24B 1.94B 1.82B 1.66B 3.12B 213B 3.14B 21.53B 8.38B 108B 8.43B 8.24B 359B EV / Sales 2026 *
1.33x
EV / Sales 2027 * 1.2x
Free-Float
34.99%
Yield 2026 *
4.78%
Yield 2027 * 5.57%
1 day-1.29%
1 week-6.42%
Current month-1.20%
1 month-3.41%
3 months-6.06%
6 months-34.30%
Current year-36.82%
1 week 4.92
Extreme 4.92
5.66
1 month 4.92
Extreme 4.92
5.72
Current year 4.53
Extreme 4.53
8.18
1 year 4.53
Extreme 4.53
9.55
3 years 3.17
Extreme 3.17
10.2
5 years 3.17
Extreme 3.17
10.2
10 years 1.36
Extreme 1.36
10.2
Manager TitleAgeSince
Chief Executive Officer 36 2021-05-31
Corporate Secretary 57 2011-08-31
Director TitleAgeSince
Director/Board Member 63 2005-03-20
Director/Board Member 66 2011-05-11
Director/Board Member 62 2018-12-30
Date Insider Type Main position Quantity % Market Cap. Importance
4/22/26 Other

Chairman

50,000 0.0014%
4/21/26 Other

Chief Executive Officer

58,500 0.0016%
3/27/26 Other

Chairman

60,000 0.0017%
Change 5-day change 1-year change 3-year change Capi.($)
-1.29%-6.42%-46.15%+21.87% 2.24B
+0.28%-5.97%+58.34%+108.22% 1,031B
+2.01%-0.71%+53.07%+68.99% 641B
+1.39%-2.18%+23.57%+75.43% 453B
-1.50%-7.04%+33.55%+33.94% 349B
+6.25%+2.04%+28.97%+46.57% 290B
-0.07%-4.12%+0.95%+11.79% 252B
+1.92%-0.93%+52.28%+70.67% 232B
+0.51%-4.52%-19.50%-54.83% 201B
+2.45%+0.77%+32.71%+95.59% 181B
Average +1.33%-3.02%+21.78%+47.82% 363.2B
Weighted average by Cap. +1.60%-3.40%+38.33%+66.37%

Financials

2026 *2027 *
Net sales 13.26B 1.69B 1.46B 1.37B 1.25B 2.35B 161B 2.36B 16.23B 6.32B 81.66B 6.35B 6.21B 271B 14.68B 1.87B 1.62B 1.52B 1.38B 2.6B 178B 2.62B 17.96B 6.99B 90.4B 7.03B 6.88B 300B
Net income 1.96B 250M 216M 203M 185M 348M 23.76B 350M 2.4B 935M 12.09B 940M 920M 40.08B 2.12B 270M 233M 219M 200M 376M 25.66B 378M 2.59B 1.01B 13.06B 1.02B 993M 43.29B
Net Debt - -
Logo Grand Pharmaceutical Group Limited
Grand Pharmaceutical Group Ltd is an investment holding company mainly engaged in the pharmaceutical business. The Company is mainly engaged in the manufacture and sale of pharmaceutical preparations and medical devices. The Company is also engaged in the manufacture and sale of biotechnology products, health products, specialised pharmaceutical raw materials and other products. The Company's main products include nuclear medicine anti-tumor diagnosis and treatment and cardiovascular and cerebrovascular interventional diagnosis and treatment technology products.
Employees
12,326
Date Price Change Volume
26-09-01 HK$4.960 -1.29% 1,956,000
26-09-01 HK$5.025 +0.10% 5,119,000
26-08-31 HK$5.020 -4.20% 7,087,500
26-08-28 HK$5.240 -0.38% 4,122,000
26-08-27 HK$5.260 -0.75% 9,452,498
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
5.025HKD
Average target price
11.26HKD
Spread / Average Target
+124.08%

Annual profits - Rate of surprise